My research interest is the development of radiotracers for applications in oncology and neuroscience. Currently, my research efforts focus on the development of radiolabeled bioactive molecules for cancer imaging, and the development of radiolabeled 2-arylbenzothiazoles for imaging amyloid plaques in the brain of Alzheimer’s disease patients.
- Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci.
- Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.
- Scalable whole-genome single-cell library preparation without preamplification.